Aripiprazole augmentation versus antidepressant switching for patients with major depressive disorder: a 6-week, randomized, rater-blinded, prospective study

C Han, SM Wang, KP Kwak, WY Won, HY Lee… - Journal of psychiatric …, 2015 - Elsevier
No study has directly compared the efficacy and tolerability of aripiprazole augmentation
(AA) and antidepressant switching (SW) in patients with major depressive disorder (MDD) …
被引用次数：46 相关文章

Aripiprazole augmentation versus antidepressant switching for patients with major depressive disorder: A 6-week, randomized, rater-blinded, prospective study

C Han, SM Wang, KP Kwak, WY Won… - Journal of Psychiatric …, 2015 - pure.korea.ac.kr
No study has directly compared the efficacy and tolerability of aripiprazole augmentation
(AA) and antidepressant switching (SW) in patients with major depressive disorder (MDD) …

Aripiprazole augmentation versus antidepressant switching for patients with major depressive disorder: A 6-week, randomized, rater-blinded, prospective study

C Han, SM Wang, KP Kwak, WY Won… - Journal of …, 2015 - cuk.elsevierpure.com
No study has directly compared the efficacy and tolerability of aripiprazole augmentation
(AA) and antidepressant switching (SW) in patients with major depressive disorder (MDD) …

Aripiprazole augmentation versus antidepressant switching for patients with major depressive disorder: A 6-week, randomized, rater-blinded, prospective study

C Han, SM Wang, KP Kwak, WY Won, H Lee… - 2015 - 210.100.220.80
No study has directly compared the efficacy and tolerability of aripiprazole augmentation
(AA) and antidepressant switching (SW) in patients with major depressive disorder (MDD) …

Aripiprazole augmentation versus antidepressant switching for patients with major depressive disorder: A 6-week, randomized, rater-blinded, prospective study

C Han, SM Wang, KP Kwak, WY Won, HY Lee… - Journal of Psychiatric …, 2015 - infona.pl
No study has directly compared the efficacy and tolerability of aripiprazole augmentation
(AA) and antidepressant switching (SW) in patients with major depressive disorder (MDD) …

Aripiprazole augmentation versus antidepressant switching for patients with major depressive disorder: A 6-week, randomized, rater-blinded, prospective study

C Han, SM Wang, KP Kwak, WY Won… - JOURNAL OF …, 2015 - scholar.korea.ac.kr
No study has directly compared the efficacy and tolerability of aripiprazole augmentation
(AA) and antidepressant switching (SW) in patients with major depressive disorder (MDD) …

Aripiprazole augmentation versus antidepressant switching for patients with major depressive disorder: A 6-week, randomized, rater-blinded, prospective study

C Han, SM Wang, KP Kwak, WY Won, HY Lee… - 2015 - pubmed.ncbi.nlm.nih.gov
No study has directly compared the efficacy and tolerability of aripiprazole augmentation
(AA) and antidepressant switching (SW) in patients with major depressive disorder (MDD) …

Aripiprazole augmentation versus antidepressant switching for patients with major depressive disorder: A 6-week, randomized, rater-blinded, prospective study.

C Han, SM Wang, KP Kwak, WY Won… - Journal of Psychiatric …, 2015 - europepmc.org
No study has directly compared the efficacy and tolerability of aripiprazole augmentation
(AA) and antidepressant switching (SW) in patients with major depressive disorder (MDD) …

[引用][C] Aripiprazole augmentation versus antidepressant switching for patients with major depressive disorder: A 6-week, randomized, rater-blinded, prospective study

C Han, SM Wang, KP Kwak, WY Won, H Lee… - 2015